These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1087726)

  • 1. Correlation between anti-DNA antibody titre and psychiatric manifestations in systemic lupus erythematosus.
    Levo Y; Kalaci J; Pick AI; Golomb M
    Postgrad Med J; 1976 Dec; 52(614):795-8. PubMed ID: 1087726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical characteristics of antibodies to DNA in patients with active systemic lupus erythematosus.
    Ballou SP; Kushner I
    Clin Exp Immunol; 1979 Jul; 37(1):58-67. PubMed ID: 385188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus].
    Pigrau A; Martínez-Vázquez JM; Bacardí R; Ocanña I; Pahissa A
    Med Clin (Barc); 1984 Dec; 83(19):787-91. PubMed ID: 6335542
    [No Abstract]   [Full Text] [Related]  

  • 4. The delayed appearance of an antinuclear factor and the diagnosis of systemic lupus erythematosus in glomerulonephritis.
    Cairns SA; Acheson EJ; Corbett CL; Dosa S; Mallick NP; Lawler W; Williams G
    Postgrad Med J; 1979 Oct; 55(648):723-7. PubMed ID: 317153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
    Davis P; Cumming RH; Verrier-Jones J
    Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Relationship between antinuclear antibodies, DNA binding capacity, and electroprecipitation, serum complement level, and the presence of soluble complexes in systemic lupus erythematosus and rheumatoid arthritis.
    Johnson GD; Onyewotu II; Holborrow EJ
    Ann Rheum Dis; 1975 Oct; 34(5):469. PubMed ID: 1083216
    [No Abstract]   [Full Text] [Related]  

  • 7. Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus affecting the central nervous system.
    Nakamura S; Yoshinari M; Saku Y; Hirakawa K; Miishima C; Murai K; Tokiyama K; Fujishima M
    Ann Rheum Dis; 1991 Oct; 50(10):713-6. PubMed ID: 1958096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for immunogenic DNA in the pathogenesis of systemic lupus erythematosus.
    Pisetsky DS; Grudier JP; Gilkeson GS
    Arthritis Rheum; 1990 Feb; 33(2):153-9. PubMed ID: 2407246
    [No Abstract]   [Full Text] [Related]  

  • 9. Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction.
    Winfield JB; Brunner CM; Koffler D
    Arthritis Rheum; 1978 Apr; 21(3):289-94. PubMed ID: 306251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus.
    Swaak AJ; Groenwold J; Bronsveld W
    Ann Rheum Dis; 1986 May; 45(5):359-66. PubMed ID: 3487292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
    Gheita TA; Abaza NM; Hammam N; Mohamed AAA; El-Gazzar II; Eissa AH
    Lupus; 2018 Jun; 27(7):1081-1087. PubMed ID: 29460701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of anti-DNA antibody titers in the early diagnosis, treatment and follow-up of systemic lupus erythematosus.
    Pick AI; Levo Y; Weiss C
    Isr J Med Sci; 1974 Jul; 10(7):725-30. PubMed ID: 4137310
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis of systemic lupus erythematosus and lupus nephritis.
    Roberts JL
    Contrib Nephrol; 1983; 35():150-69. PubMed ID: 6339160
    [No Abstract]   [Full Text] [Related]  

  • 14. Low avidity antibodies to double stranded DNA in systemic lupus erythematosus: a longitudinal study of their clinical significance.
    Nossent JC; Huysen V; Smeenk RJ; Swaak AJ
    Ann Rheum Dis; 1989 Aug; 48(8):677-82. PubMed ID: 2789501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum anti-dsDNA antibodies in lupus nephritis].
    Fiorentini GP; Cagnoli L
    Boll Soc Ital Biol Sper; 1981 Sep; 57(18):1890-5. PubMed ID: 7032540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of an immediate hypersensitivity mechanism in systemic lupus erythematosus.
    Egido J; Sánchez Crespo M; Lahoz C; García R; López-Trascasa M; Hernando L
    Ann Rheum Dis; 1980 Aug; 39(4):312-7. PubMed ID: 6969064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serological switching from anti-dsDNA to anti-Sm antibodies coincided with severe clinical manifestations of systemic lupus erythematosus (hemophagocytosis, profundus and psychosis).
    Ishii M; Muramoto Y; Kosaka H; Ohshima S; Mima T; Katada Y; Hirohata S; Saeki Y
    Lupus; 2007; 16(1):67-9. PubMed ID: 17283590
    [No Abstract]   [Full Text] [Related]  

  • 18. Qualitative characteristics of anti-DNA antibodies in lupus nephritis.
    Gershwin ME; Steinberg AD
    Arthritis Rheum; 1974; 17(6):947-54. PubMed ID: 4215428
    [No Abstract]   [Full Text] [Related]  

  • 19. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
    Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
    Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lupus erythematosus glomerulonephritis in children.
    Garin EH; Shulman ST; Donnelly WH; Richard GA
    Paediatrician; 1981; 10(5-6):351-67. PubMed ID: 6460214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.